BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12366664)

  • 21. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Carcinogenic mechanisms of multiple genes in cervical carcinoma].
    Huang G; Xiao X; Huang Y; Huang R
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):5-9. PubMed ID: 9208611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular oncogenes and suppressor genes as prognostic markers in cancer.
    Duffy MJ
    Clin Biochem; 1993 Dec; 26(6):439-47. PubMed ID: 8124858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping.
    Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Woods J; Finkelstein SD
    Int J Gynecol Pathol; 2000 Apr; 19(2):110-7. PubMed ID: 10782406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].
    Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G
    C R Acad Sci III; 1984; 299(14):575-80. PubMed ID: 6097348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix.
    Symonds RP; Habeshaw T; Paul J; Kerr DJ; Darling A; Burnett RA; Sotsiou F; Linardopoulos S; Spandidos DA
    Eur J Cancer; 1992; 28A(10):1615-7. PubMed ID: 1389474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer genes alterations and HPV infection in oral squamous cell carcinoma.
    Popović B; Jekić B; Novaković I; Luković L; Konstantinović V; Babić M; Milasin J
    Int J Oral Maxillofac Surg; 2010 Sep; 39(9):909-15. PubMed ID: 20579853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
    Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
    Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
    Sun B; Ye X; Li Y; Zhang W
    Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.
    Dürst M; Croce CM; Gissmann L; Schwarz E; Huebner K
    Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1070-4. PubMed ID: 3029760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.
    Halle MK; Ojesina AI; Engerud H; Woie K; Tangen IL; Holst F; Høivik E; Kusonmano K; Haldorsen IS; Vintermyr OK; Trovik J; Bertelsen BI; Salvesen HB; Krakstad C
    Am J Obstet Gynecol; 2017 Oct; 217(4):432.e1-432.e17. PubMed ID: 28599900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
    Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.